Type 1 Diabetes Mellitus: evidence brief
Open Source Medicine Foundation · page built 16 November 2026 · trial data searched 2026-11-16 (capped at 1,000 of 2,071 matching trials) · https://research.opensourcemed.info/briefs/type-1-diabetes.html
Research information, not medical advice. Prepared to support a conversation with a clinician, not to choose a treatment.
Medicines with registered trials
Scale: trials listed for each medicine on the tracker's condition page, a snapshot of ClinicalTrials.gov. A trial means it is being studied, not that it works.
- Insulin Lispro 3 trials
- LY900014 2 trials
- Acetazolamide 1 trial
- Acetylated and Butyrylated High Amylose Maize Starch 1 trial
- Allogeneic CD7-Targeted CAR-T Cell Injection 1 trial
- Alpha 1-Antitrypsin (AAT, Aralast NP) 1 trial
Non-drug approaches tested
Scale: trial status on ClinicalTrials.gov (completed, results posted). Status is not a result.
- Wearables and monitoring devices 65 trials · 31 completed · 21 with results
- Education, coaching and self-management 95 trials · 48 completed · 14 with results
- Dietary patterns and specific diets 28 trials · 13 completed · 7 with results
- Vitamin D 11 trials · 9 completed · 6 with results
- Aerobic and endurance exercise 16 trials · 8 completed · 2 with results
- Psychotherapy, counselling and peer support 17 trials · 6 completed · 2 with results
Natural products (RepurpOS Moderate tier)
Scale: RepurpOS evidence tier, from linked trials and literature. Product quality and dose vary.
- Vitamin D3
- Omega-3 Fatty Acids
- Magnesium
- Vitamin C
- Zinc
- Saffron
Biomarkers reported
Direction in patients compared with the stated comparison group, as reported in the cited study.
- C-Peptide lower · Yu et al. 2019
- Fasting Plasma Glucose higher · Yang et al. 2024
- GAD65 autoantibodies higher · Luo et al. 2004
- HbA1c higher · Pasi et al. 2022
- IA-2 autoantibodies higher · Mendis et al. 2023
- ZnT8 autoantibodies higher · Bhola et al. 2021
Trials recruiting
Status as recorded on ClinicalTrials.gov when searched (2026-11-16); check the registry for current status and eligibility.
- INfluenza VaccInation To Mitigate typE 1 Diabetes NCT05585983
- Lean Mass Changes With Semaglutide in Adults With Type 1 Diabetes and… NCT07891156
- A Study of GNTI-122 in Adults Recently Diagnosed With T1D NCT06919354
- Finding Immune Nascent Type 1 Diabetes NCT07663136
- Glycemic Improvement With Team, Technology, Education and Peer Resources in Type 1… NCT07097805
- Intensive Dietary and Activity Counselling (IDAC) NCT06670625
What we don't know yet
Gaps in registered trials, from the evidence-gap map. A gap is not a recommendation.
- Mind-body and psychological approaches: mood, anxiety and wellbeing 16 trials, no results posted yet
- Cognitive training and education: feasibility, adherence and safety 15 trials, no results posted yet